Canton Strategic Holdings, Inc. (CNTN)
2.21
+0.13
(+6.25%)
USD |
NASDAQ |
Sep 03, 15:05
Canton Strategic Holdings Shareholders Equity (Quarterly) : 454.90M for June 30, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 454.90M |
| March 31, 2026 | 469.80M |
| December 31, 2025 | 397.93M |
| September 30, 2025 | 6.155M |
| June 30, 2025 | 0.3674M |
| March 31, 2025 | -0.8147M |
| December 31, 2024 | 1.308M |
| September 30, 2024 | 3.018M |
| June 30, 2024 | 6.694M |
| March 31, 2024 | 7.049M |
| December 31, 2023 | 9.131M |
| Date | Value |
|---|---|
| September 30, 2023 | 1.757M |
| June 30, 2023 | 3.069M |
| March 31, 2023 | 3.201M |
| December 31, 2022 | 5.544M |
| September 30, 2022 | 7.116M |
| June 30, 2022 | 9.040M |
| March 31, 2022 | 10.34M |
| December 31, 2021 | -4.685M |
| September 30, 2021 | -7.145M |
| June 30, 2021 | -6.296M |
| March 31, 2021 | -5.294M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Arrowhead Pharmaceuticals, Inc. | 465.53M |
| Oncolytics Biotech, Inc. | -6.167M |
| Sangamo Therapeutics, Inc. | -18.96M |
| Sarepta Therapeutics, Inc. | 1.528B |
| Anixa Biosciences, Inc. | 14.48M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 564.57M |
| Total Liabilities (Quarterly) | 109.67M |
| Current Ratio | 15.70 |
| Net Debt Paydown Yield | 0.05% |